We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Controlling the Transient Activation of Protein Kinases in Living Cells

By LabMedica International staff writers
Posted on 27 Dec 2016
Print article
Image: The molecular model of tyrosine kinase c-Src (Src) (Photo courtesy of Wikimedia Commons).
Image: The molecular model of tyrosine kinase c-Src (Src) (Photo courtesy of Wikimedia Commons).
The study of the effects of protein kinase enzymes in living cells has been enhanced by the development of a technique to control when and for how long a specific kinase is active.

Protein kinases, which transfer phosphate from the energy molecule ATP to other enzymes and proteins, are involved in almost every biological process. While significant progress has been made in defining the role of many kinases, understanding how specific kinases orchestrate complex signaling events remains challenging.

Investigators at the University of Illinois, Chicago (USA) have described a method to control the timing and the duration of kinase activity. This system provides the ability to mimic physiologically relevant transient activation of a kinase.

They reported in the December 12, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that by using two protein-engineering approaches, they could achieve independent control of kinase activation and inactivation. They demonstrated successful regulation of tyrosine kinase c-Src (Src) and Ser/Thr kinase p38alpha (p38), demonstrating the broad applicability of the method. By using this approach, they identified morphological changes induced by transient activation of Src and demonstrated the role of sequential Src-PI3K (Phosphoinositide 3-kinase) and Src-Rac1 (Ras-related C3 botulinum toxin substrate 1) signaling in regulation of cell morphology.

"Previously, we had the ability to artificially turn on a kinase, but we did not know how to turn it off," said senior author Dr. Andrei Karginov, assistant professor of pharmacology in the University of Illinois, Chicago. "So what we could see was only the result of that kinase being on for a long time. But, in living cells, kinases are often turned only for a set period of time, and the duration of this activation often dictates what will happen to the cell. To mimic this transient action we had come up with a new strategy."

Related Links:
University of Illinois, Chicago

Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.